{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-21-012630","form_type":"8-K","ticker":"ZOMDF","cik":"0001684144","company_name":"Zomedica Corp.","filed_at":"2021-11-26T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.672312+00:00","generated_at":"2026-06-28T05:19:09.248909+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Zomedica CCO Bruk Herbst departs; separation agreement with benefits for termination without cause","bullets":["Bruk Herbst separated from Zomedica as Chief Commercial Officer effective Nov 19, 2021.","Separation agreement provides benefits for termination without cause per his employment agreement and home office equipment (excluding laptop).","Agreement includes mutual release of claims, confidentiality, non-disparagement, and non-solicitation obligations.","Herbst had 21 days to consider and 7 days to revoke the agreement; it was signed on Nov 19, 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-21-012630","json":"https://secwatch.observer/filing/0001654954-21-012630.json","markdown":"https://secwatch.observer/filing/0001654954-21-012630.md","text":"https://secwatch.observer/filing/0001654954-21-012630.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1684144/000165495421012630/0001654954-21-012630-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1684144/000165495421012630/zom_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T05:19:09.248909+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1c6d4e410d","claim":"Bruk Herbst departed as Chief Commercial Officer at Zomedica Corp..","evidence_excerpt":"On November 19, 2021, Bruk Herbst was separated from employment as Chief Commercial Officer of Zomedica Corp. (the “Company”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1684144/000165495421012630/0001654954-21-012630-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"separated from employment"},{"label":"Role","value":"Chief Commercial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}